We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GRMN:NYSEGarmin Ltd. Analysis

Data as of 2026-03-10 - not real-time

$238.61

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Garmin posted a robust 17% revenue growth YoY, with healthy gross (58.7%) and operating margins (28.9%). Earnings per share jumped to $8.59 and the forward estimate is $10.17, while cash balances exceed $2.7B and debt is modest, supporting a 40% payout ratio and a dividend yield of 1.73%. The stock trades at $238.61, just above the 20‑day SMA ($237.78) and below the 50‑day SMA, with an RSI of 55 and a bearish MACD histogram, indicating a neutral‑to‑slightly‑downward short‑term momentum. However, the DCF fair value of $126 is far below the current price, yet the PE ratio (27.8) is well under the industry average (36.7) and analysts’ median target of $258 suggests ~9% upside.
Risk is heightened by a 30‑day volatility of over 40% and a beta around 1.2, while volume trends are weakening, pointing to liquidity concerns. Nonetheless, the company’s diversified exposure across fitness, aviation, marine and automotive segments, low regulatory headwinds, and strong cash flow make the dividend sustainable. The overall picture favors a hold for the immediate term but a buy outlook over medium to long horizons as earnings momentum and dividend growth continue.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish MACD histogram and decreasing volume
  • Price hovering near 20‑day SMA with neutral RSI
  • Limited upside to immediate resistance at $256

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 17% revenue growth and expanding margins
  • Analyst median target price of $258 indicating ~9% upside
  • Sustainable dividend with low payout ratio and solid cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified product portfolio across high‑growth segments (fitness, aviation, marine)
  • Robust balance sheet with ample cash and low leverage
  • Consistent earnings expansion and potential dividend increases

Key Metrics & Analysis

Financial Health

Revenue Growth16.60%
Profit Margin22.96%
P/E Ratio27.8
ROE19.78%
ROA11.37%
Debt/Equity2.18
P/B Ratio5.1
Op. Cash Flow$1.6B
Free Cash Flow$790.9M
Industry P/E36.7

Technical Analysis

TrendNeutral
RSI55.0
Support$201.19
Resistance$256.80
MA 20$237.78
MA 50$218.97
MA 200$220.62
MACDBearish
VolumeDecreasing
Fear & Greed Index76.84

Valuation

Fair Value$126.46
Target Price$260.25
Upside/Downside9.07%
GradeFair
TypeBlend
Dividend Yield1.73%

Risk Assessment

Beta1.22
Volatility41.49%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.